Show simple item record

dc.contributor.authorKutikov, Artem B.
dc.contributor.authorSkelly, Jordan D.
dc.contributor.authorAyers, David C.
dc.contributor.authorSong, Jie
dc.date2022-08-11T08:08:31.000
dc.date.accessioned2022-08-23T15:58:04Z
dc.date.available2022-08-23T15:58:04Z
dc.date.issued2015-03-04
dc.date.submitted2015-05-18
dc.identifier.citationACS Appl Mater Interfaces. 2015 Mar 4;7(8):4890-901. doi: 10.1021/am508984y. <a href="http://dx.doi.org/10.1021/am508984y">Link to article on publisher's site</a>
dc.identifier.issn1944-8244 (Linking)
dc.identifier.doi10.1021/am508984y
dc.identifier.pmid25695310
dc.identifier.urihttp://hdl.handle.net/20.500.14038/30346
dc.description<p>First author Artem B. Kutikov is a doctoral student in the Cell Biology program in the Graduate School of Biomedical Sciences (GSBS) at UMass Medical School.</p>
dc.description.abstractEffective repair of critical-size long bone defects presents a significant clinical challenge. Electrospun scaffolds can be exploited to deliver protein therapeutics and progenitor cells, but their standalone application for long bone repair has not been explored. We have previously shown that electrospun composites of amphiphilic poly(d,l-lactic acid)-co-poly(ethylene glycol)-co-poly(d,l-lactic acid) (PELA) and hydroxyapatite (HA) guide the osteogenic differentiation of bone marrow stromal cells (MSCs), making these scaffolds uniquely suited for evaluating cell-based bone regeneration approaches. Here we examine whether the in vitro bioactivity of these electrospun scaffolds can be exploited for long bone defect repair, either through the participation of exogenous MSCs or through the activation of endogenous cells by a low dose of recombinant human bone morphogenetic protein-2 (rhBMP-2). In critical-size rat femoral segmental defects, spiral-wrapped electrospun HA-PELA with preseeded MSCs resulted in laminated endochondral ossification templated by the scaffold across the longitudinal span of the defect. Using GFP labeling, we confirmed that the exogenous MSCs adhered to HA-PELA survived at least 7 days postimplantation, suggesting direct participation of these exogenous cells in templated bone formation. When loaded with 500 ng of rhBMP-2, HA-PELA spirals led to more robust but less clearly templated bone formation than MSC-bearing scaffolds. Both treatment groups resulted in new bone bridging over the majority of the defect by 12 weeks. This study is the first demonstration of a standalone bioactive electrospun scaffold for templated bone formation in critical-size long bone defects.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=25695310&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttp://dx.doi.org/10.1021/am508984y
dc.subjectBiomaterials
dc.subjectCell and Developmental Biology
dc.subjectMolecular, Cellular, and Tissue Engineering
dc.subjectMusculoskeletal Diseases
dc.subjectOrthopedics
dc.subjectPolymer Chemistry
dc.titleTemplated repair of long bone defects in rats with bioactive spiral-wrapped electrospun amphiphilic polymer/hydroxyapatite scaffolds
dc.typeJournal Article
dc.source.journaltitleACS applied materials and interfaces
dc.source.volume7
dc.source.issue8
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/faculty_pubs/616
dc.identifier.contextkey7111905
html.description.abstract<p>Effective repair of critical-size long bone defects presents a significant clinical challenge. Electrospun scaffolds can be exploited to deliver protein therapeutics and progenitor cells, but their standalone application for long bone repair has not been explored. We have previously shown that electrospun composites of amphiphilic poly(d,l-lactic acid)-co-poly(ethylene glycol)-co-poly(d,l-lactic acid) (PELA) and hydroxyapatite (HA) guide the osteogenic differentiation of bone marrow stromal cells (MSCs), making these scaffolds uniquely suited for evaluating cell-based bone regeneration approaches. Here we examine whether the in vitro bioactivity of these electrospun scaffolds can be exploited for long bone defect repair, either through the participation of exogenous MSCs or through the activation of endogenous cells by a low dose of recombinant human bone morphogenetic protein-2 (rhBMP-2). In critical-size rat femoral segmental defects, spiral-wrapped electrospun HA-PELA with preseeded MSCs resulted in laminated endochondral ossification templated by the scaffold across the longitudinal span of the defect. Using GFP labeling, we confirmed that the exogenous MSCs adhered to HA-PELA survived at least 7 days postimplantation, suggesting direct participation of these exogenous cells in templated bone formation. When loaded with 500 ng of rhBMP-2, HA-PELA spirals led to more robust but less clearly templated bone formation than MSC-bearing scaffolds. Both treatment groups resulted in new bone bridging over the majority of the defect by 12 weeks. This study is the first demonstration of a standalone bioactive electrospun scaffold for templated bone formation in critical-size long bone defects.</p>
dc.identifier.submissionpathfaculty_pubs/616
dc.contributor.departmentDepartment of Cell and Developmental Biology
dc.contributor.departmentDepartment of Orthopedics and Physical Rehabilitation
dc.source.pages4890-901


This item appears in the following Collection(s)

Show simple item record